Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing - Wikidata - wikimedia - TriplyDB

Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

http://www.wikidata.org/entity/Q34382581

about

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer Cell-free circulating tumor DNA in cancer Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis Methylation analyses in liquid biopsy Normal and Cancerous Tissues Release extrachromosomal circular DNA (eccDNA) into the Circulation.Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments Methy-Pipe: an integrated bioinformatics pipeline for whole genome bisulfite sequencing data analysis Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease.Circulating Tumor DNA as Biomarkers for Cancer Detection.Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing.Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.DNA markers in molecular diagnostics for hepatocellular carcinoma.Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD.RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.IDH1 mutation detection by droplet digital PCR in glioma.Simultaneous single-molecule epigenetic imaging of DNA methylation and hydroxymethylation.Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.Profile of Dennis Lo.Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA.Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.Prognostic DNA methylation markers for prostate cancer.Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.Current and future molecular diagnostics in non-small-cell lung cancer.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA The impact of digital DNA counting technologies on noninvasive prenatal testing.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Integrating liquid biopsies into the management of cancer.Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer.Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer.Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet.

P2860

Q26746010-E69EE9EA-C491-4CBA-B525-0FB255A35089 Q26750899-3AA7782E-C428-4A1E-ACC2-7D46581BB301 Q26787260-A9570DFB-FA83-4FC9-BD45-AC17C23DB5BA Q28072859-4F6734B5-5E5D-40C5-B7EE-8E3FB635DABF Q30252331-AABB4224-436E-489C-AB69-47EC92707AD4 Q30667824-AC3E7A97-9485-478B-BCAB-3F96FB3D0EFA Q30832210-44485320-FE12-437C-A6A5-80F57F148948 Q33557917-9729F65B-21AF-4765-929B-12BE08DC3BF1 Q33632125-552DA686-F541-4D85-9447-9BE76AFF7C22 Q33767643-CA19359D-68E4-40DF-80B3-7EB6E98DE720 Q34620256-92CD296D-DA7C-481B-ACAA-6966C20A6644 Q34709085-BE3DBE27-D1A8-43FF-81F7-E21DAE5DEC29 Q35212779-13BF7016-05F2-4FEC-A88D-E6C23114802D Q35781255-92E6068B-059C-4AF8-905D-929C678EB06F Q36009225-356A315D-0A67-4FB8-A8F1-DA73E83F85E6 Q36038684-0FB83A1D-C211-427E-AC14-33FF6D9B0416 Q36278318-EDD6BBD5-3568-4161-A33E-E8389C306C08 Q36545444-F580AC98-607C-42E3-99C7-0E695EA6F2BB Q36831563-6C4D775B-773D-44C5-B96A-68080347F89D Q37175458-B28EA0A8-4D66-47FE-A9D1-C977519C6EFE Q37194027-BBE1B37C-4E91-4311-93A7-49055AF7BE9E Q37340939-C18359CF-26C0-44A5-81B5-F89B0AD00B92 Q37690677-0FB735DF-011E-4DB3-956D-950C9C42C3CE Q37719554-0ACDBDDA-721A-468E-A163-60FBB2568FF8 Q38201707-B3FB50FE-2E91-40AB-8C51-B9603B2C49FE Q38252624-13C9C8F9-762E-4203-A3D1-FDCCCA831F2A Q38261856-1F707EF6-41EB-493F-933E-45D71708DF9D Q38270678-99C33D7C-6925-42C4-85C8-9C815EBD834B Q38543780-C5C7049D-5F3C-46AB-A810-82B13F1D6DA5 Q38549770-37D3536D-7272-4502-9CF0-2181AE742520 Q38584359-3C058703-DD87-4C6E-B681-008FAA393E61 Q38700222-F32EEE16-9899-448B-9D4A-D9740E7C06D2 Q38959017-BC4B7889-5890-4412-B0F9-443EA738AD76 Q39003554-9183690B-00A0-4FC5-9C31-9244046A5E07 Q39149201-1DE53081-716E-4CED-BAEB-1E1B155B144B Q39157824-415C3029-5300-412D-A673-502FD6EE8D39 Q40368914-A1376DB6-3B77-491A-960E-42DDC2A80BC7 Q40528885-26B4BB83-F543-46CE-9056-C31413BA17EE Q40890323-FBA9BB34-012B-416E-953F-3D6AD0AA1BD8 Q41021645-D1ADF358-F9A2-4586-8934-3B8F95F12DDC

P2860

Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

http://www.wikidata.org/entity/Q34382581

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@ast

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@en

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@nl

type

label

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@ast

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@en

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@nl

prefLabel

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@ast

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@en

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@nl

P1433

Q34382581-C26C7FE9-210B-4472-822A-688C561CC3D2

P1476

Q34382581-67986828-EFF0-430E-8AA8-1FAB9BAF980D

P2093

Q34382581-04A748C4-1ECD-410A-880C-66458DFF6BBF

Q34382581-46072C74-92A7-4F37-A9B4-3276C3701129

Q34382581-4FD24619-9C11-4EE5-8BC7-323C605C9FF7

Q34382581-584735FD-02EC-4C13-8645-23D798CA18F1

Q34382581-602197FD-278F-4C9B-BFEA-AE21523134EC

Q34382581-630D2596-6F26-4ABA-9AC3-6106A22EDA90

Q34382581-68EEFE11-6AE7-4723-B593-C3FA01F08B7F

Q34382581-B0E47373-EF93-45BE-9107-BB064525DE2A

Q34382581-B252EBD7-627F-4EF8-A0D6-BC38A951A6CA

Q34382581-BB45C4FA-F336-437E-8940-277D7C5BD645

P2860

Q34382581-0557EFD9-89B6-456B-B462-8DF7CB1BCD87

Q34382581-0EA644E8-7E96-4E7B-BAF9-347DEC75EA60

Q34382581-25F9BAC3-B87E-4D73-A6FD-03AFD224BCB4

Q34382581-3CCDA7ED-A30F-499C-886C-B5D559236027

Q34382581-438F1D92-6C3A-434A-8B76-629761F2B91A

Q34382581-45CBD9ED-2614-4B29-BD24-154B2EC92F7C

Q34382581-46EE55A3-69CD-4F5A-B734-0D763F428007

Q34382581-4AA19806-B8FB-4D8F-97D7-81B4F3BD2A24

Q34382581-5DEB28EA-0EED-4A7A-A54A-8A190834BA85

Q34382581-6292B92D-6C48-4126-8DB3-2B310E409567

P304

Q34382581-3B840AD4-A541-4847-B274-6296D8C33AF9

P31

Q34382581-D2B70F25-036C-403D-A8AF-2881F9F487F9

P356

Q34382581-7A1EEF26-9326-4918-AE06-3352DC6A4C01

P407

Q34382581-5F223E4A-99A1-4219-8AD8-C329B38CE46E

P433

Q34382581-53B3FCC8-C936-443F-8294-45343F5D9EA0

P478

Q34382581-2AE9E31D-901B-4A3F-AF77-C239A5476B9E

P50

Q34382581-0FDC4722-4670-45BA-8303-77FA06B667A2

Q34382581-553D3828-F887-4508-9126-4A19F00A9159

Q34382581-B9980947-22B2-4C55-A395-FEDF8391ECA4

P577

Q34382581-DEF01B3B-77F5-4CFE-9BAA-C1D94334DBF5

P5875

Q34382581-62F2BE2E-CAFD-45E4-AA2C-A52B00A97BD2

P698

Q34382581-EFDDAA5D-5B8A-49DC-93EE-EF1E99C53FCF

P932

Q34382581-705C254E-DF77-4F0A-A0BD-7DDD122CA7C9

P356

PNAS.1313995110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Noninvasive detection of cance ...... lasma DNA bisulfite sequencing

@en

P2093

Anthony T C Chan

http://www.w3.org/2001/XMLSchema#string

Brigette B Y Ma

http://www.w3.org/2001/XMLSchema#string

Carol W M Chan

http://www.w3.org/2001/XMLSchema#string

Cesar S C Wong

http://www.w3.org/2001/XMLSchema#string

David S C Hui

http://www.w3.org/2001/XMLSchema#string

Edwin P Hui

http://www.w3.org/2001/XMLSchema#string

Henry L Y Chan

http://www.w3.org/2001/XMLSchema#string

John Wong

http://www.w3.org/2001/XMLSchema#string

K C Allen Chan

http://www.w3.org/2001/XMLSchema#string

Paul B S Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Human DNA methylomes at base resolution show widespread epigenomic differences

SOAP2: an improved ultrafast tool for short read alignment

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

pROC: an open-source package for R and S+ to analyze and compare ROC curves

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Detection of the placental epigenetic signature of the maspin gene in maternal plasma.

Cell-free nucleic acids as biomarkers in cancer patients.

P304

18761-18768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1313995110

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258282653

http://www.w3.org/2001/XMLSchema#string

P698

24191000

http://www.w3.org/2001/XMLSchema#string

P932

3839703

http://www.w3.org/2001/XMLSchema#string